Contractor
Name	Contract
Type	Contract
Number	Jurisdiction	States
Novitas
Solutions, Inc.	A and B
MAC	04111 -
MAC A	J - H	Colorado
Novitas
Solutions, Inc.	A and B
MAC	04112 -
MAC B	J - H	Colorado
Novitas
Solutions, Inc.	A and B
MAC	04211 -
MAC A	J - H	New Mexico
Novitas
Solutions, Inc.	A and B
MAC	04212 -
MAC B	J - H	New Mexico
Novitas
Solutions, Inc.	A and B
MAC	04311 -
MAC A	J - H	Oklahoma
Novitas
Solutions, Inc.	A and B
MAC	04312 -
MAC B	J - H	Oklahoma
Novitas
Solutions, Inc.	A and B
MAC	04411 -
MAC A	J - H	Texas
Contractor
Name	Contract
Type	Contract
Number	Jurisdiction	States
Novitas
Solutions, Inc.	A and B
MAC	04412 -
MAC B	J - H	Texas
Novitas
Solutions, Inc.	A and B
MAC	04911 -
MAC A	J - H	Colorado
New Mexico
Oklahoma
Texas
Novitas
Solutions, Inc.	A and B
MAC	07101 -
MAC A	J - H	Arkansas
Novitas
Solutions, Inc.	A and B
MAC	07102 -
MAC B	J - H	Arkansas
Novitas
Solutions, Inc.	A and B
MAC	07201 -
MAC A	J - H	Louisiana
Novitas
Solutions, Inc.	A and B
MAC	07202 -
MAC B	J - H	Louisiana
Novitas
Solutions, Inc.	A and B
MAC	07301 -
MAC A	J - H	Mississippi
Novitas
Solutions, Inc.	A and B
MAC	07302 -
MAC B	J - H	Mississippi
Novitas
Solutions, Inc.	A and B
MAC	12101 -
MAC A	J - L	Delaware
Novitas
Solutions, Inc.	A and B
MAC	12102 -
MAC B	J - L	Delaware
Contractor
Name	Contract
Type	Contract
Number	Jurisdiction	States
Novitas
Solutions, Inc.	A and B
MAC	12201 -
MAC A	J - L	District of
Columbia
Novitas
Solutions, Inc.	A and B
MAC	12202 -
MAC B	J - L	District of
Columbia
Novitas
Solutions, Inc.	A and B
MAC	12301 -
MAC A	J - L	Maryland
Novitas
Solutions, Inc.	A and B
MAC	12302 -
MAC B	J - L	Maryland
Novitas
Solutions, Inc.	A and B
MAC	12401 -
MAC A	J - L	New Jersey
Novitas
Solutions, Inc.	A and B
MAC	12402 -
MAC B	J - L	New Jersey
Novitas
Solutions, Inc.	A and B
MAC	12501 -
MAC A	J - L	Pennsylvania
Novitas
Solutions, Inc.	A and B
MAC	12502 -
MAC B	J - L	Pennsylvania
Novitas
Solutions, Inc.	A and B
MAC	12901 -
MAC A	J - L	Delaware
District of
Columbia
Maryland
New Jersey
Pennsylvania
Code	Description
81120	Idh1 common variants
81121	Idh2 common variants
81170	Abl1 gene
81175	Asxl1 full gene sequence
81176	Asxl1 gene target seq alys
81206	Bcr/abl1 gene major bp
81207	Bcr/abl1 gene minor bp
81208	Bcr/abl1 gene other bp
81210	Braf gene
81218	Cebpa gene full sequence
81219	Calr gene com variants
81233	Btk gene common variants
81235	Egfr gene com variants
81236	Ezh2 gene full gene sequence
Code	Description
81237	Ezh2 gene common variants
81245	Flt3 gene
81246	Flt3 gene analysis
81261	Igh gene rearrange amp meth
81262	Igh gene rearrang dir probe
81263	Igh vari regional mutation
81270	Jak2 gene
81272	Kit gene targeted seq analys
81273	Kit gene analys d816 variant
81275	Kras gene variants exon 2
81276	Kras gene addl variants
81287	Mgmt gene prmtr mthyltn alys
81292	Mlh1 gene full seq
81293	Mlh1 gene known variants
81294	Mlh1 gene dup/delete variant
81301	Microsatellite instability
Code	Description
81305	Myd88 gene p.leu265pro vrnt
81310	Npm1 gene
81311	Nras gene variants exon 2&3
81313	Pca3/klk3 antigen
81314	Pdgfra gene
81315	Pml/raralpha com breakpoints
81316	Pml/raralpha 1 breakpoint
81320	Plcg2 gene common variants
81321	Pten gene full sequence
81322	Pten gene known fam variant
81323	Pten gene dup/delet variant
81327	Sept9 gen prmtr mthyltn alys
81334	Runx1 gene targeted seq alys
81340	Trb@ gene rearrange amplify
81342	Trg gene rearrangement anal
81345	Tert gene targeted seq alys
Code	Description
81347	Sf3b1 gene common variants
81348	Srsf2 gene common variants
81351	Tp53 gene full gene sequence
81352	Tp53 gene trgt sequence alys
81353	Tp53 gene known famil vrnt
81357	U2af1 gene common variants
81360	Zrsr2 gene common variants
81435	Hered colon ca-rlatd do 5+
81437	Hered neuroend tum-rlt do 5+
81445	So neo gsap 5-50dna/dna&rna
81450	Hl neo gsap 5-50dna/dna&rna
81479	Unlisted molecular pathology
81503	Onco (ovar) five proteins
81520	Onc breast mrna 58 genes
81525	Oncology colon mrna
81538	Oncology lung
Code	Description
81540	Oncology tum unknown origin
81546	Onc thyr mrna 10,196 gen alg
0018U	Onc thyr 10 microrna seq alg
0026U	Onc thyr dna&mrna 112 genes
0245U	Onc thyr mut alys 10 gen&37
Code	Description
C17.0	Malignant neoplasm of duodenum
C17.1	Malignant neoplasm of jejunum
C17.2	Malignant neoplasm of ileum
C17.3	Meckel's diverticulum, malignant
C17.8	Malignant neoplasm of overlapping sites of small intestine
C17.9	Malignant neoplasm of small intestine, unspecified
C18.0	Malignant neoplasm of cecum
C18.1	Malignant neoplasm of appendix
C18.2	Malignant neoplasm of ascending colon
C18.3	Malignant neoplasm of hepatic flexure
C18.4	Malignant neoplasm of transverse colon
Code	Description
C18.5	Malignant neoplasm of splenic flexure
C18.6	Malignant neoplasm of descending colon
C18.7	Malignant neoplasm of sigmoid colon
C18.8	Malignant neoplasm of overlapping sites of colon
C18.9	Malignant neoplasm of colon, unspecified
C19	Malignant neoplasm of rectosigmoid junction
C20	Malignant neoplasm of rectum
C21.0	Malignant neoplasm of anus, unspecified
C21.1	Malignant neoplasm of anal canal
C21.2	Malignant neoplasm of cloacogenic zone
C21.8	Malignant neoplasm of overlapping sites of rectum, anus and anal
canal
Z85.030	Personal history of malignant carcinoid tumor of large intestine
Z85.038	Personal history of other malignant neoplasm of large intestine
Z85.040	Personal history of malignant carcinoid tumor of rectum
Z85.048	Personal history of other malignant neoplasm of rectum,
rectosigmoid junction, and anus
Code	Description
C33	Malignant neoplasm of trachea
C34.00	Malignant neoplasm of unspecified main bronchus
C34.01	Malignant neoplasm of right main bronchus
C34.02	Malignant neoplasm of left main bronchus
C34.10	Malignant neoplasm of upper lobe, unspecified bronchus or lung
C34.11	Malignant neoplasm of upper lobe, right bronchus or lung
C34.12	Malignant neoplasm of upper lobe, left bronchus or lung
C34.2	Malignant neoplasm of middle lobe, bronchus or lung
Code	Description
C34.30	Malignant neoplasm of lower lobe, unspecified bronchus or lung
C34.31	Malignant neoplasm of lower lobe, right bronchus or lung
C34.32	Malignant neoplasm of lower lobe, left bronchus or lung
C34.80	Malignant neoplasm of overlapping sites of unspecified bronchus
and lung
C34.81	Malignant neoplasm of overlapping sites of right bronchus and lung
C34.82	Malignant neoplasm of overlapping sites of left bronchus and lung
C34.90	Malignant neoplasm of unspecified part of unspecified bronchus or
lung
C34.91	Malignant neoplasm of unspecified part of right bronchus or lung
C34.92	Malignant neoplasm of unspecified part of left bronchus or lung
C38.4	Malignant neoplasm of pleura
C45.0	Mesothelioma of pleura
Code	Description
C43.0	Malignant melanoma of lip
C43.10	Malignant melanoma of unspecified eyelid, including canthus
C43.111	Malignant melanoma of right upper eyelid, including canthus
C43.112	Malignant melanoma of right lower eyelid, including canthus
C43.121	Malignant melanoma of left upper eyelid, including canthus
C43.122	Malignant melanoma of left lower eyelid, including canthus
C43.20	Malignant melanoma of unspecified ear and external auricular
canal
C43.21	Malignant melanoma of right ear and external auricular canal
C43.22	Malignant melanoma of left ear and external auricular canal
C43.30	Malignant melanoma of unspecified part of face
C43.31	Malignant melanoma of nose
C43.39	Malignant melanoma of other parts of face
C43.4	Malignant melanoma of scalp and neck
Code	Description
C43.51	Malignant melanoma of anal skin
C43.52	Malignant melanoma of skin of breast
C43.59	Malignant melanoma of other part of trunk
C43.60	Malignant melanoma of unspecified upper limb, including shoulder
C43.61	Malignant melanoma of right upper limb, including shoulder
C43.62	Malignant melanoma of left upper limb, including shoulder
C43.70	Malignant melanoma of unspecified lower limb, including hip
C43.71	Malignant melanoma of right lower limb, including hip
C43.72	Malignant melanoma of left lower limb, including hip
C43.8	Malignant melanoma of overlapping sites of skin
C43.9	Malignant melanoma of skin, unspecified
D03.0	Melanoma in situ of lip
D03.10	Melanoma in situ of unspecified eyelid, including canthus
D03.111	Melanoma in situ of right upper eyelid, including canthus
D03.112	Melanoma in situ of right lower eyelid, including canthus
D03.121	Melanoma in situ of left upper eyelid, including canthus
Code	Description
D03.122	Melanoma in situ of left lower eyelid, including canthus
D03.20	Melanoma in situ of unspecified ear and external auricular canal
D03.21	Melanoma in situ of right ear and external auricular canal
D03.22	Melanoma in situ of left ear and external auricular canal
D03.30	Melanoma in situ of unspecified part of face
D03.39	Melanoma in situ of other parts of face
D03.4	Melanoma in situ of scalp and neck
D03.51	Melanoma in situ of anal skin
D03.52	Melanoma in situ of breast (skin) (soft tissue)
D03.59	Melanoma in situ of other part of trunk
D03.60	Melanoma in situ of unspecified upper limb, including shoulder
D03.61	Melanoma in situ of right upper limb, including shoulder
D03.62	Melanoma in situ of left upper limb, including shoulder
D03.70	Melanoma in situ of unspecified lower limb, including hip
D03.71	Melanoma in situ of right lower limb, including hip
D03.72	Melanoma in situ of left lower limb, including hip
Code	Description
D03.8	Melanoma in situ of other sites
D03.9	Melanoma in situ, unspecified
Code	Description
C69.01	Malignant neoplasm of right conjunctiva
C69.02	Malignant neoplasm of left conjunctiva
C69.11	Malignant neoplasm of right cornea
C69.12	Malignant neoplasm of left cornea
C69.21	Malignant neoplasm of right retina
C69.22	Malignant neoplasm of left retina
C69.31	Malignant neoplasm of right choroid
Code	Description
C69.32	Malignant neoplasm of left choroid
C69.41	Malignant neoplasm of right ciliary body
C69.42	Malignant neoplasm of left ciliary body
C69.51	Malignant neoplasm of right lacrimal gland and duct
C69.52	Malignant neoplasm of left lacrimal gland and duct
C69.61	Malignant neoplasm of right orbit
C69.62	Malignant neoplasm of left orbit
C69.81	Malignant neoplasm of overlapping sites of right eye and adnexa
C69.82	Malignant neoplasm of overlapping sites of left eye and adnexa
Code	Description
C71.0	Malignant neoplasm of cerebrum, except lobes and ventricles
C71.1	Malignant neoplasm of frontal lobe
C71.2	Malignant neoplasm of temporal lobe
C71.3	Malignant neoplasm of parietal lobe
C71.4	Malignant neoplasm of occipital lobe
C71.5	Malignant neoplasm of cerebral ventricle
C71.6	Malignant neoplasm of cerebellum
C71.7	Malignant neoplasm of brain stem
C71.8	Malignant neoplasm of overlapping sites of brain
C71.9	Malignant neoplasm of brain, unspecified
Code	Description
C73*	Malignant neoplasm of thyroid gland
D34	Benign neoplasm of thyroid gland
D44.0	Neoplasm of uncertain behavior of thyroid gland
D44.2*	Neoplasm of uncertain behavior of parathyroid gland
D44.9	Neoplasm of uncertain behavior of unspecified endocrine gland
E01.0	Iodine-deficiency related diffuse (endemic) goiter
E01.1	Iodine-deficiency related multinodular (endemic) goiter
E01.2	Iodine-deficiency related (endemic) goiter, unspecified
E04.0	Nontoxic diffuse goiter
E04.1	Nontoxic single thyroid nodule
E04.2	Nontoxic multinodular goiter
Code	Description
E04.8	Other specified nontoxic goiter
E04.9	Nontoxic goiter, unspecified
Code	Description
C45.1	Mesothelioma of peritoneum
C48.1	Malignant neoplasm of specified parts of peritoneum
Code	Description
C48.2	Malignant neoplasm of peritoneum, unspecified
C48.8	Malignant neoplasm of overlapping sites of retroperitoneum and
peritoneum
C54.0	Malignant neoplasm of isthmus uteri
C54.1	Malignant neoplasm of endometrium
C54.2	Malignant neoplasm of myometrium
C54.3	Malignant neoplasm of fundus uteri
C54.8	Malignant neoplasm of overlapping sites of corpus uteri
C54.9	Malignant neoplasm of corpus uteri, unspecified
C55	Malignant neoplasm of uterus, part unspecified
C56.1	Malignant neoplasm of right ovary
C56.2	Malignant neoplasm of left ovary
C56.3	Malignant neoplasm of bilateral ovaries
C56.9	Malignant neoplasm of unspecified ovary
C57.00	Malignant neoplasm of unspecified fallopian tube
C57.01	Malignant neoplasm of right fallopian tube
Code	Description
C57.02	Malignant neoplasm of left fallopian tube
C57.10	Malignant neoplasm of unspecified broad ligament
C57.11	Malignant neoplasm of right broad ligament
C57.12	Malignant neoplasm of left broad ligament
C57.20	Malignant neoplasm of unspecified round ligament
C57.21	Malignant neoplasm of right round ligament
C57.22	Malignant neoplasm of left round ligament
C57.3	Malignant neoplasm of parametrium
C57.4	Malignant neoplasm of uterine adnexa, unspecified
Code	Description
Code	Description
C65.1	Malignant neoplasm of right renal pelvis
C65.2	Malignant neoplasm of left renal pelvis
C65.9	Malignant neoplasm of unspecified renal pelvis
C66.1	Malignant neoplasm of right ureter
C66.2	Malignant neoplasm of left ureter
C66.9	Malignant neoplasm of unspecified ureter
C68.0	Malignant neoplasm of urethra
C68.1	Malignant neoplasm of paraurethral glands
C68.8	Malignant neoplasm of overlapping sites of urinary organs
C68.9	Malignant neoplasm of urinary organ, unspecified
Code	Description
C61	Malignant neoplasm of prostate
D29.1	Benign neoplasm of prostate
D40.0	Neoplasm of uncertain behavior of prostate
N40.0	Benign prostatic hyperplasia without lower urinary tract symptoms
N40.1	Benign prostatic hyperplasia with lower urinary tract symptoms
N40.2	Nodular prostate without lower urinary tract symptoms
N40.3	Nodular prostate with lower urinary tract symptoms
N42.31	Prostatic intraepithelial neoplasia
N42.32	Atypical small acinar proliferation of prostate
N42.39	Other dysplasia of prostate
N42.83	Cyst of prostate
R31.1	Benign essential microscopic hematuria
R31.29	Other microscopic hematuria
Code	Description
C49.A0	Gastrointestinal stromal tumor, unspecified site
C49.A1	Gastrointestinal stromal tumor of esophagus
C49.A2	Gastrointestinal stromal tumor of stomach
C49.A3	Gastrointestinal stromal tumor of small intestine
C49.A4	Gastrointestinal stromal tumor of large intestine
C49.A5	Gastrointestinal stromal tumor of rectum
C49.A9	Gastrointestinal stromal tumor of other sites
D48.19	Other specified neoplasm of uncertain behavior of connective and
other soft tissue
D48.2	Neoplasm of uncertain behavior of peripheral nerves and autonomic
nervous system
Code	Description
C91.00	Acute lymphoblastic leukemia not having achieved remission
C91.01	Acute lymphoblastic leukemia, in remission
C91.02	Acute lymphoblastic leukemia, in relapse
Code	Description
C92.00	Acute myeloblastic leukemia, not having achieved remission
C92.01	Acute myeloblastic leukemia, in remission
C92.02	Acute myeloblastic leukemia, in relapse
C92.40	Acute promyelocytic leukemia, not having achieved remission
C92.41	Acute promyelocytic leukemia, in remission
C92.42	Acute promyelocytic leukemia, in relapse
C92.50	Acute myelomonocytic leukemia, not having achieved remission
Code	Description
C92.51	Acute myelomonocytic leukemia, in remission
C92.52	Acute myelomonocytic leukemia, in relapse
C92.60	Acute myeloid leukemia with 11q23-abnormality not having
achieved remission
C92.61	Acute myeloid leukemia with 11q23-abnormality in remission
C92.62	Acute myeloid leukemia with 11q23-abnormality in relapse
C92.A0	Acute myeloid leukemia with multilineage dysplasia, not having
achieved remission
C92.A1	Acute myeloid leukemia with multilineage dysplasia, in remission
C92.A2	Acute myeloid leukemia with multilineage dysplasia, in relapse
Code	Description
Code	Description
C91.40	Hairy cell leukemia not having achieved remission
C91.41	Hairy cell leukemia, in remission
C91.42	Hairy cell leukemia, in relapse
Code	Description
D60.0	Chronic acquired pure red cell aplasia
D60.1	Transient acquired pure red cell aplasia
D60.8	Other acquired pure red cell aplasias
D60.9	Acquired pure red cell aplasia, unspecified
D61.01	Constitutional (pure) red blood cell aplasia
D61.03	Fanconi anemia
Code	Description
D61.09	Other constitutional aplastic anemia
D61.1	Drug-induced aplastic anemia
D61.2	Aplastic anemia due to other external agents
D61.3	Idiopathic aplastic anemia
D61.89	Other specified aplastic anemias and other bone marrow failure
syndromes
D61.9	Aplastic anemia, unspecified
Code	Description
C83.70	Burkitt lymphoma, unspecified site
C83.71	Burkitt lymphoma, lymph nodes of head, face, and neck
C83.72	Burkitt lymphoma, intrathoracic lymph nodes
Code	Description
C83.73	Burkitt lymphoma, intra-abdominal lymph nodes
C83.74	Burkitt lymphoma, lymph nodes of axilla and upper limb
C83.75	Burkitt lymphoma, lymph nodes of inguinal region and lower limb
C83.76	Burkitt lymphoma, intrapelvic lymph nodes
C83.77	Burkitt lymphoma, spleen
C83.78	Burkitt lymphoma, lymph nodes of multiple sites
C83.79	Burkitt lymphoma, extranodal and solid organ sites
C83.7A	Burkitt lymphoma, in remission
Code	Description
D45	Polycythemia vera
D47.1	Chronic myeloproliferative disease
D47.3	Essential (hemorrhagic) thrombocythemia
D75.81	Myelofibrosis
Code	Description
Code	Description
C92.10	Chronic myeloid leukemia, BCR/ABL-positive, not having achieved
remission
C92.11	Chronic myeloid leukemia, BCR/ABL-positive, in remission
C92.12	Chronic myeloid leukemia, BCR/ABL-positive, in relapse
C93.10	Chronic myelomonocytic leukemia not having achieved remission
C93.11	Chronic myelomonocytic leukemia, in remission
C93.12	Chronic myelomonocytic leukemia, in relapse
Code	Description
Code	Description
C91.10	Chronic lymphocytic leukemia of B-cell type not having achieved
remission
C91.11	Chronic lymphocytic leukemia of B-cell type in remission
C91.12	Chronic lymphocytic leukemia of B-cell type in relapse
Code	Description
C91.Z0	Other lymphoid leukemia not having achieved remission
C91.Z1	Other lymphoid leukemia, in remission
C91.Z2	Other lymphoid leukemia, in relapse
Code	Description
D72.110	Idiopathic hypereosinophilic syndrome [IHES]
D72.111	Lymphocytic Variant Hypereosinophilic Syndrome [LHES]
D72.118	Other hypereosinophilic syndrome
D72.119	Hypereosinophilic syndrome [HES], unspecified
Code	Description
C96.20	Malignant mast cell neoplasm, unspecified
C96.22	Mast cell sarcoma
Code	Description
C96.29	Other malignant mast cell neoplasm
Code	Description
C91.60	Prolymphocytic leukemia of T-cell type not having achieved
remission
C91.61	Prolymphocytic leukemia of T-cell type, in remission
C91.62	Prolymphocytic leukemia of T-cell type, in relapse
C95.90	Leukemia, unspecified not having achieved remission
C95.91	Leukemia, unspecified, in remission
C95.92	Leukemia, unspecified, in relapse
Code	Description
D46.0	Refractory anemia without ring sideroblasts, so stated
D46.1	Refractory anemia with ring sideroblasts
D46.20	Refractory anemia with excess of blasts, unspecified
D46.21	Refractory anemia with excess of blasts 1
D46.22	Refractory anemia with excess of blasts 2
D46.A	Refractory cytopenia with multilineage dysplasia
Code	Description
D46.B	Refractory cytopenia with multilineage dysplasia and ring
sideroblasts
D46.C	Myelodysplastic syndrome with isolated del(5q) chromosomal
abnormality
D46.4	Refractory anemia, unspecified
D46.Z	Other myelodysplastic syndromes
D46.9	Myelodysplastic syndrome, unspecified
Code	Description
C90.00*	Multiple myeloma not having achieved remission
C90.02*	Multiple myeloma in relapse
Code	Description
C50.011	Malignant neoplasm of nipple and areola, right female breast
C50.012	Malignant neoplasm of nipple and areola, left female breast
C50.111	Malignant neoplasm of central portion of right female breast
C50.112	Malignant neoplasm of central portion of left female breast
C50.211	Malignant neoplasm of upper-inner quadrant of right female breast
C50.212	Malignant neoplasm of upper-inner quadrant of left female breast
C50.311	Malignant neoplasm of lower-inner quadrant of right female breast
C50.312	Malignant neoplasm of lower-inner quadrant of left female breast
C50.411	Malignant neoplasm of upper-outer quadrant of right female
breast
C50.412	Malignant neoplasm of upper-outer quadrant of left female breast
C50.511	Malignant neoplasm of lower-outer quadrant of right female breast
Code	Description
C50.512	Malignant neoplasm of lower-outer quadrant of left female breast
C50.611	Malignant neoplasm of axillary tail of right female breast
C50.612	Malignant neoplasm of axillary tail of left female breast
C50.811	Malignant neoplasm of overlapping sites of right female breast
C50.812	Malignant neoplasm of overlapping sites of left female breast
C50.911	Malignant neoplasm of unspecified site of right female breast
C50.912	Malignant neoplasm of unspecified site of left female breast
Code	Description
C7A.010	Malignant carcinoid tumor of the duodenum
C7A.011	Malignant carcinoid tumor of the jejunum
C7A.012	Malignant carcinoid tumor of the ileum
C7A.019	Malignant carcinoid tumor of the small intestine, unspecified
portion
C7A.020	Malignant carcinoid tumor of the appendix
C7A.021	Malignant carcinoid tumor of the cecum
C7A.022	Malignant carcinoid tumor of the ascending colon
C7A.023	Malignant carcinoid tumor of the transverse colon
C7A.024	Malignant carcinoid tumor of the descending colon
C7A.025	Malignant carcinoid tumor of the sigmoid colon
C7A.026	Malignant carcinoid tumor of the rectum
C7A.029	Malignant carcinoid tumor of the large intestine, unspecified
portion
C7A.090	Malignant carcinoid tumor of the bronchus and lung
C7A.091	Malignant carcinoid tumor of the thymus
Code	Description
C7A.092	Malignant carcinoid tumor of the stomach
C7A.093	Malignant carcinoid tumor of the kidney
C7A.094	Malignant carcinoid tumor of the foregut, unspecified
C7A.095	Malignant carcinoid tumor of the midgut, unspecified
C7A.096	Malignant carcinoid tumor of the hindgut, unspecified
C7A.098	Malignant carcinoid tumors of other sites
C7A.1	Malignant poorly differentiated neuroendocrine tumors
C7A.8	Other malignant neuroendocrine tumors
C7B.01	Secondary carcinoid tumors of distant lymph nodes
C7B.02	Secondary carcinoid tumors of liver
C7B.03	Secondary carcinoid tumors of bone
C7B.04	Secondary carcinoid tumors of peritoneum
C7B.09	Secondary carcinoid tumors of other sites
C7B.1	Secondary Merkel cell carcinoma
C7B.8	Other secondary neuroendocrine tumors
D3A.010	Benign carcinoid tumor of the duodenum
Code	Description
D3A.011	Benign carcinoid tumor of the jejunum
D3A.012	Benign carcinoid tumor of the ileum
D3A.019	Benign carcinoid tumor of the small intestine, unspecified portion
D3A.020	Benign carcinoid tumor of the appendix
D3A.021	Benign carcinoid tumor of the cecum
D3A.022	Benign carcinoid tumor of the ascending colon
D3A.023	Benign carcinoid tumor of the transverse colon
D3A.024	Benign carcinoid tumor of the descending colon
D3A.025	Benign carcinoid tumor of the sigmoid colon
D3A.026	Benign carcinoid tumor of the rectum
D3A.029	Benign carcinoid tumor of the large intestine, unspecified portion
D3A.090	Benign carcinoid tumor of the bronchus and lung
D3A.091	Benign carcinoid tumor of the thymus
D3A.092	Benign carcinoid tumor of the stomach
D3A.093	Benign carcinoid tumor of the kidney
D3A.094	Benign carcinoid tumor of the foregut, unspecified
Code	Description
D3A.095	Benign carcinoid tumor of the midgut, unspecified
D3A.096	Benign carcinoid tumor of the hindgut, unspecified
D3A.098	Benign carcinoid tumors of other sites
D3A.8	Other benign neuroendocrine tumors
Code	Description
C18.1	Malignant neoplasm of appendix
C18.9	Malignant neoplasm of colon, unspecified
C22.0	Liver cell carcinoma
C22.2	Hepatoblastoma
C22.3	Angiosarcoma of liver
C22.4	Other sarcomas of liver
Code	Description
C22.7	Other specified carcinomas of liver
C22.8	Malignant neoplasm of liver, primary, unspecified as to type
C22.9	Malignant neoplasm of liver, not specified as primary or secondary
C25.2	Malignant neoplasm of tail of pancreas
C25.7	Malignant neoplasm of other parts of pancreas
C25.8	Malignant neoplasm of overlapping sites of pancreas
C25.9	Malignant neoplasm of pancreas, unspecified
C33	Malignant neoplasm of trachea
C34.01	Malignant neoplasm of right main bronchus
C34.02	Malignant neoplasm of left main bronchus
C34.11	Malignant neoplasm of upper lobe, right bronchus or lung
C34.12	Malignant neoplasm of upper lobe, left bronchus or lung
C34.2	Malignant neoplasm of middle lobe, bronchus or lung
C34.32	Malignant neoplasm of lower lobe, left bronchus or lung
C34.81	Malignant neoplasm of overlapping sites of right bronchus and
lung
Code	Description
C34.82	Malignant neoplasm of overlapping sites of left bronchus and lung
C34.91	Malignant neoplasm of unspecified part of right bronchus or lung
C34.92	Malignant neoplasm of unspecified part of left bronchus or lung
C43.51	Malignant melanoma of anal skin
C43.52	Malignant melanoma of skin of breast
C43.59	Malignant melanoma of other part of trunk
C45.9	Mesothelioma, unspecified
C47.0	Malignant neoplasm of peripheral nerves of head, face and neck
C47.9	Malignant neoplasm of peripheral nerves and autonomic nervous
system, unspecified
C48.0	Malignant neoplasm of retroperitoneum
C49.0	Malignant neoplasm of connective and soft tissue of head, face
and neck
C49.9	Malignant neoplasm of connective and soft tissue, unspecified
C50.411	Malignant neoplasm of upper-outer quadrant of right female
breast
C50.412	Malignant neoplasm of upper-outer quadrant of left female breast
	Code	Description	
	C50.511	Malignant neoplasm of lower-outer quadrant of right female breast	
	C50.512	Malignant neoplasm of lower-outer quadrant of left female breast	
	C50.811	Malignant neoplasm of overlapping sites of right female breast	
	C50.812	Malignant neoplasm of overlapping sites of left female breast	
	C50.911	Malignant neoplasm of unspecified site of right female breast	
	C50.912	Malignant neoplasm of unspecified site of left female breast	
	C56.1	Malignant neoplasm of right ovary	
	C56.2	Malignant neoplasm of left ovary	
	C56.3	Malignant neoplasm of bilateral ovaries	
	C61	Malignant neoplasm of prostate	
	C64.1	Malignant neoplasm of right kidney, except renal pelvis	
	C64.2	Malignant neoplasm of left kidney, except renal pelvis	
	C67.5	Malignant neoplasm of bladder neck	
	C67.9	Malignant neoplasm of bladder, unspecified	
	C76.0	Malignant neoplasm of head, face and neck	
	C77.0	Secondary and unspecified malignant neoplasm of lymph nodes of	
			
			
	Code	Description	
		head, face and neck	
	C77.1	Secondary and unspecified malignant neoplasm of intrathoracic
lymph nodes	
	C77.2	Secondary and unspecified malignant neoplasm of intra-
abdominal lymph nodes	
	C77.3	Secondary and unspecified malignant neoplasm of axilla and
upper limb lymph nodes	
	C77.4	Secondary and unspecified malignant neoplasm of inguinal and
lower limb lymph nodes	
	C77.5	Secondary and unspecified malignant neoplasm of intrapelvic
lymph nodes	
	C77.8	Secondary and unspecified malignant neoplasm of lymph nodes of
multiple regions	
	C77.9	Secondary and unspecified malignant neoplasm of lymph node,
unspecified	
	C78.01	Secondary malignant neoplasm of right lung	
	C78.02	Secondary malignant neoplasm of left lung	
	C78.5	Secondary malignant neoplasm of large intestine and rectum	
	C78.6	Secondary malignant neoplasm of retroperitoneum and
peritoneum	
	C78.7	Secondary malignant neoplasm of liver and intrahepatic bile duct	
Code	Description
C79.01	Secondary malignant neoplasm of right kidney and renal pelvis
C79.02	Secondary malignant neoplasm of left kidney and renal pelvis
C79.2	Secondary malignant neoplasm of skin
C79.31	Secondary malignant neoplasm of brain
C79.49	Secondary malignant neoplasm of other parts of nervous system
C79.51	Secondary malignant neoplasm of bone
C79.52	Secondary malignant neoplasm of bone marrow
C79.61	Secondary malignant neoplasm of right ovary
C79.62	Secondary malignant neoplasm of left ovary
C79.63	Secondary malignant neoplasm of bilateral ovaries
C79.89	Secondary malignant neoplasm of other specified sites
C80.0	Disseminated malignant neoplasm, unspecified
C80.1	Malignant (primary) neoplasm, unspecified
C82.57	Diffuse follicle center lymphoma, spleen
C84.A7	Cutaneous T-cell lymphoma, unspecified, spleen
C84.Z7	Other mature T/NK-cell lymphomas, spleen
Code	Description
C84.97	Mature T/NK-cell lymphomas, unspecified, spleen
C85.17	Unspecified B-cell lymphoma, spleen
C85.27	Mediastinal (thymic) large B-cell lymphoma, spleen
C85.87	Other specified types of non-Hodgkin lymphoma, spleen
C85.97	Non-Hodgkin lymphoma, unspecified, spleen
C86.10	Hepatosplenic T-cell lymphoma not having achieved remission
D01.5	Carcinoma in situ of liver, gallbladder and bile ducts
D01.7	Carcinoma in situ of other specified digestive organs
D01.9	Carcinoma in situ of digestive organ, unspecified
D02.21	Carcinoma in situ of right bronchus and lung
D02.22	Carcinoma in situ of left bronchus and lung
D03.51	Melanoma in situ of anal skin
D03.52	Melanoma in situ of breast (skin) (soft tissue)
D03.59	Melanoma in situ of other part of trunk
D49.0	Neoplasm of unspecified behavior of digestive system
D49.1	Neoplasm of unspecified behavior of respiratory system
Code	Description
D49.2	Neoplasm of unspecified behavior of bone, soft tissue, and skin
D49.3	Neoplasm of unspecified behavior of breast
D49.4	Neoplasm of unspecified behavior of bladder
D49.511	Neoplasm of unspecified behavior of right kidney
D49.512	Neoplasm of unspecified behavior of left kidney
D49.59	Neoplasm of unspecified behavior of other genitourinary organ
D49.6	Neoplasm of unspecified behavior of brain
D49.7	Neoplasm of unspecified behavior of endocrine glands and other
parts of nervous system
D49.89	Neoplasm of unspecified behavior of other specified sites
D49.9	Neoplasm of unspecified behavior of unspecified site
J91.0	Malignant pleural effusion
Code	Description
C67.0	Malignant neoplasm of trigone of bladder
C67.1	Malignant neoplasm of dome of bladder
C67.2	Malignant neoplasm of lateral wall of bladder
C67.3	Malignant neoplasm of anterior wall of bladder
C67.4	Malignant neoplasm of posterior wall of bladder
C67.5	Malignant neoplasm of bladder neck
C67.6	Malignant neoplasm of ureteric orifice
C67.7	Malignant neoplasm of urachus
C67.8	Malignant neoplasm of overlapping sites of bladder
C67.9	Malignant neoplasm of bladder, unspecified
Code	Description
C88.00	Waldenstrom macroglobulinemia not having achieved remission
Code	Description
XX000	Not Applicable
Code	Description
999x	Not Applicable
Code	Description
99999	Not Applicable
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
	04/24/2025	R48	Article revised and published on 05/01/2025.
References to CPT code 81438 have been changed to
81479.	
	04/24/2025	R47	Article revised and published on 04/24/2025 effective
for dates of service on and after 04/24/2025. In
response to the Genetic Testing in Oncology: Specific
Tests Billing and Coding article (A59125) becoming
effective CPT code 0287U for ThyroSeq CRC has been
removed from this article. Additionally, the information
specific to UroVysion along with CPT codes 88120 and
88121 have been removed from the article. Finally, the
information regarding Colvera along with CPT code
0229U has been removed from the article. Please refer
to A59125 for billing and coding information related to
the services removed from this article.	
	01/01/2025	R46	Article revised and published on 01/30/2025 effective
for dates of service on and after 01/01/2025 to reflect
the annual CPT/HCPCS Code Updates. The following
Group 1 codes have descriptor revisions: 81435 and
81437. The following codes have been deleted and
therefore remove from the article: 81436 and 81438.
Coding guidance has been added to the Article
Guidance section.	
	10/01/2024	R45	Article revised and published on 10/24/2024 effective
for dates of service on and after 10/01/2024 to reflect
the Annual ICD-10-CM Code Updates. The following
code has been deleted and therefore removed from	
Revision
History
Date	Revision
History
Number	Revision History Explanation
		Group 27 Codes: C86.1. The following code has been
deleted and therefore removed from Group 29 Codes:
C88.0. The following codes have been added: D61.03
to Group 14 Codes, C83.7A to Group 15 Codes, C86.10
to Group 27 Codes, and C88.00 to Group 29 Codes.
02/29/2024	R44	Article revised and published on 02/29/2024 to correct
the Note in the CPT/HCPCS Codes Group 1 Paragraph.
This paragraph was inadvertently changed with the
10/26/2023 revision. The diagnosis limitations outlined
in the various ICD-10-CM Codes that Support Medical
Necessity groups continue to apply.
01/01/2024	R43	Article revised and published on 01/25/2024 effective
for dates of service on and after 01/01/2024 to reflect
the Annual HCPCS/CPT Code Updates. For the
following CPT codes either the short description and/or
the long description was changed. Depending on which
description is used in this article, there may not be any
change in how the code displays: 81445 and 81450 in
Group 1 CPT/HCPCS Codes.
10/01/2023	R42	Article revised and published on 10/26/2023 effective
for dates of service on and after 10/01/2023 to reflect
the Annual ICD-10-CM Code Updates. The following
ICD-10-CM code has been deleted and therefore has
been removed from the article: D48.1 in Group 10
Codes. The following ICD-10-CM code has been added
to the article: D48.19 in Group 10 Codes. Minor
formatting changes have been made throughout the
article.
Revision
History
Date	Revision
History
Number	Revision History Explanation
08/07/2023	R41	Article revised and published on 09/07/2023 effective
for dates of service on and after 08/07/2023 to remove
the link and to revise the verbiage referring to NCD
90.2 located in the ICD-10-CM Codes that Support
Medical Necessity Group 1 Paragraph. The link for
NCD 90.2 has been added to the Associated
Documents section at the bottom of this article under
Related National Coverage Documents.
08/07/2023	R40	Article revised and published on 08/31/2023 effective
for dates of service on and after 08/07/2023 with the
updated link to NCD 90.2 Transmittal TN 12017 in
response to CMS Change Request (CR) 13166. This
updated link is located in the ICD-10-CM Codes that
Support Medical Necessity Group 1 Paragraph.
01/01/2023	R39	Article revised and published on 01/26/2023 effective
for dates of service on and after 01/01/2023 to reflect
the Annual HCPCS/CPT Code Updates. For the
following CPT codes either the short description and/or
the long description was changed. Depending on which
description is used in this article, there may not be any
change in how the code displays: 81445 and 81450. In
response to an inquiry the Group 6 Medical Necessity
ICD-10-CM Codes Asterisk Explanation note has been
revised effective for dates of service on or after
05/15/2018 to reflect that C73 should not be reported
for ThyraMIR, Afirma, Rosetta GX Reveal, or
ThyGeNEXT and that D44.2 should not be reported for
ThyraMIR, Afirma, Rosetta GX Reveal, ThyGeNEXT or
ThyroSeq.
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
	10/01/2022	R38	Article revised and published on 10/06/2022 effective
for dates of service on and after 10/01/2022 to reflect
the Quarter 4 Quarterly CPT/HCPCS Code Updates.
CPT code 0229U underwent either a short description
and/or long description change. Depending on which
description was changed there may not be any change
in how the code displays.	
	07/01/2022	R37	Article revised and published on 08/04/2022 effective
for dates of service on and after 07/01/2022 to reflect
the July Quarterly CPT/HCPCS Code Update. For the
following CPT code either the short description and/or
the long description was changed. Depending on which
description is used in this article, there may not be any
change in how the code displays: 0229U in the ‘CPT/
HCPCS Codes’ section for ‘Group 1 Codes’.	
	01/30/2022	R36	Article revised and published on 01/27/2022 effective
for dates of service on and after 01/30/2022. Tier 2
codes 81400 thru 81405 have been removed from the
CPT code ‘Group1’. Additionally, billing & coding
instructions specific for the Tier 2 codes have been
removed from the article along with formatting
changes throughout the article.	
	01/01/2022	R35	Article revised and published on 01/20/2022 effective
for dates of service on and after 01/01/2022 to reflect
the Annual HCPCS/CPT Code Updates. CPT code
0287U has been added to the following sections:
Under ‘Coding Guidance’ in the ‘Test Panel Definition’
section for ThyroSeq Tests; In the ‘Selected Oncology
Tests’ section under Bullet #7 in the directions ‘To	
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
			report ThyroSeq Thyroid tests’; In the ‘CPT/HCPCS
Codes’ section for ‘Group 1 Codes’ and; In the ‘ICD-10-
CM Codes that Support Medical Necessity’ section for
‘Group 6 Paragraph’ for ThyroSeq. For the following
CPT code either the short description and/or the long
description was changed. Depending on which
description is used in this article, there may not be any
change in how the code displays: 81405.	
	12/12/2021	R34	Article revised and published on 12/9/2021 effective for
dates of service on and after 12/12/2021 to remove the
following Group 1 CPT codes: 81350, 81406, 81407
and 81408. These codes have been removed due to the
new Pharmacogenomics article becoming effective.	
	10/01/2021	R33	Article revised and published on 10/14/2021 effective
for dates of service on and after 10/01/2021 to reflect
the Annual ICD-10-CM Code updates.
The following ICD-10-CM code has been added to the
Group 7 ICD-10-CM codes that support medical
necessity: C56.3.
The following ICD-10-CM codes have been added to
the Group 27 ICD-10-CM codes that support medical
necessity: C56.3 and C79.63.	
	09/30/2021	R32	Article revised and published on 09/30/2021 effective
for dates of service on and after 1/1/2021 in response
to an inquiry. The ‘Selected Oncology Tests’ section has
been revised to add bullet #15 for the Colvera® test
(BCAT1/IKZF1 promoter hypermethylation), the ‘CPT/
HCPCS Codes’ section has been revised for the ‘Group	
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
			1 Codes’ to add CPT code 0229U, the ‘ICD-10-CM
Codes that Support Medical Necessity’ section has
been revised for the ‘Group 1 Paragraph’ to add
BCAT1/IKZF1 promoter methylation 0229U, and the
following ICD-10-CM codes have been added to the
Group 1 Codes: Z85.030, Z85.038, Z85.040 and
Z85.048.	
	04/01/2021	R31	Article revised and published on 04/22/2021 effective
for dates of service on and after 04/01/2021 in
response to the April 1, 2021 CPT code updates. The
following CPT code has been added to the Article:
0245U under group 1 and ICD10 group 6.
The following CPT code has been deleted and therefore
has been removed from the text of the article, from
CPT/HCPCS Code Group 1 and from ICD-10 Code
Group 6 Paragraph: 81455.	
	01/01/2021	R30	Article revised and published on 02/11/2021 effective
for dates of service on 01/01/2021 to add codes 81347,
81348, 81351, 81352, 81353, 81357, 81360 and
81546 to the list of group 1 CPT/HCPCS codes. 81347
has been added to group 18 paragraph to report
SF3B1, 81348 has been added to group 12 paragraph
to report SRSF2, 81351, 81352 and 81353 have been
added to group paragraphs 12 & 16 to report TP53,
81357 has been added to group 12 paragraph to
report U2AF1, 81360 has been added to group 12
paragraph to report ZRSR2, 81546 has been added to
group 6 paragraph to report oncology thyroid mRNA
and replaces the deleted code 81545. CPT code 81545
has been deleted and replaced with code 81546 in the	
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
			group 1 codes, group 6 paragraph, Test Panel
Definition and Selected Oncology Tests sections. The
following codes have descriptor revisions: 81206,
81207, 81436.	
	12/13/2020	R29	Article revised and published on 11/05/2020 effective
for dates of service on and after 12/13/2020 to add Tgt
gen seq dna&ma 23 gene to the Article Text under
Oncomine DX Test and to add FLT3D835 81245 to
Group 12 Paragraph.	
	12/13/2020	R28	Article revised in response to DL35396 and published
on 10/29/2020 effective for dates of service on and
after 12/13/2020 to add the following leukemia
biomarkers and corresponding Current Procedural
Terminology (CPT) codes: Group 11 – JAK1, NOTCH1,
FBXW7 (81479), NRAS (81311); Group 12 – U2AF1,
SRSF2, ZRSR2 (81479); Group 16 – KIT (81272,
81273); Group 18 – BIRC3, SF3B1 (81479), BTK
(81233), PLCG2 (81320); Group 19 – STAT5B (81479);
Group 22 – JAK1, JAK3 (81479). Added a group
paragraph and group ICD-10 codes for T-cell Large
Granular Lymphocytic Leukemia biomarkers STAT5B
(81479), renumbered the group paragraphs and group
codes. Procedure codes 81445, 81450 and 81455 have
been removed from all group paragraphs as they will
not have procedure to diagnosis editing. The following
note has been removed from the Group 1 Paragraph as
these codes do not have procedure to diagnosis
editing: "Please note that because the following CPT
codes represent multiple biomarkers these codes will
not have procedure to diagnosis code limitations at this
time: 81246, 81350, 81400, 81401, 81402, 81403,	
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
			81404, 81405, 81406, 81407, 81408, 81435, 81436,
81450. and 81503." Also effective 10/01/2020, for
dates of service on and after 10/01/2020, to reflect the
annual ICD-10-CM Code Updates, the following
ICD-10-CM code has been deleted and therefore
removed from the Article Code Group 20: D72.1. The
following ICD-10-CM code(s) have been added to the
Article Code Group 20: D72.110, D72.111, D72.118,
and D72.119. Minor formatting revisions made
throughout the article.	
	10/01/2020	R27	Article revised and published on 10/01/2020 effective
for dates of service on and after 10/01/2020 to reflect
the Annual ICD-10-CM Code Updates. The following
ICD-10-CM code(s) have been added to the Article
Code Group 19: D72.110, D72.111, D72.118, and
D72.119. The following ICD-10-CM code has been
deleted and therefore has been removed from the
Article Code Group 19: D72.1. The notes in ICD-10
Code Groups 6 and 23 were moved to the bottom of
the table in the asterisk explanation paragraph and
asterisks were added to the ICD-10 codes in the
groups as applicable.	
	07/01/2020	R26	Article revised and published on 06/25/2020 effective
for dates of service on and after 07/01/2020, as a non-
discretionary update to remove the Group 2 paragraph
and CPT codes. Minor formatting changes were made.	
	01/01/2020	R25	Article revised and published on 01/16/2020 effective
for dates of service on and after 01/01/2020 to reflect
the annual CPT/HCPCS code updates. The following	
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
			CPT code(s) either have a short description or long
description change. Depending on which description is
used in this article, there may not be any change in
how the code displays in the document: 81350, 81404,
81406 and 81407. Minor formatting changes and
spelling errors have been corrected throughout the
article.	
	07/10/2019	R24	Article revised and published on 09/12/2019 effective
for dates of service on and after 07/10/2019. The CPT
code for ThyraMIR has been changed from 81479 to
0018U in the Test Panel Definitions, Intended use of
ThyraMIR sections, added to the Group 1 codes, and
the Group 6 paragraph. Due to system changes in
response to CMS Change Request 10901, this article
has undergone some reorganization in the coding
section and the following new fields have been added:
CPT/HCPCS Modifier, Additional ICD-10 Information,
and Other Coding Information. There has been no
change to the LCD coverage as a result of this revision.	
	06/13/2019	R23	Article revised and published on 09/12/2019 effective
for dates of service on and after 07/10/2019. The CPT
code for ThyraMIR has been changed from 81479 to
0018U in the Test Panel Definitions, Intended use of
ThyraMIR sections, added to the Group 1 codes, and
the Group 6 paragraph. There has been no change to
the LCD coverage as a result of this revision.	
	06/13/2019	R22	Article revised and published on 06/13/2019 effective
for dates of service on and after 03/27/2019 the
following CPT code has been removed from the CPT/	
				
Revision Revision
History History
Date Number Revision History Explanation
HCPCS Code Group 2 and added to CPT/HCPCS Code
Group 1 in response to an inquiry; it will have no
diagnosis to procedure code restrictions at this time:
81450. This change is a clarification to ensure proper
billing. The CPT and ICD-10 codes from related LCD,
L35396-Biomarkers for Oncology, have been added in
response to CMS Change Request 10901. The coding
guidance section has been updated accordingly. There
has been no change to the LCD coverage indications as
a result of this revision.
04/04/2019 R21 Article revised and published on 04/04/2019 effective
for dates of service on and after 03/16/2018 to remove
CPT code 0022U from CPT/HCPCS Code Group 1 due
to implementation of NCD 90.2. Statement and link
added to ICD-10 Group 1 Paragraph stating ICD-10-
CM diagnosis codes for CPT code 0022U may be found
in NCD 90.2, Next Generation Sequencing (NGS) for
Patients with Advanced Cancer. NCD 90.2 listed as a
Related National Coverage Document.
01/01/2019 R20 Article revised and published on 02/14/2019 effective
for dates of service on and after 01/01/2019 to reflect
the annual CPT/HCPCS code updates. The following
CPT/HCPCS code(s) have been added to Group 1
Codes: 81233, 81236, 81237, 81305, 81320, and
81345. For the following CPT/HCPCS codes either the
short description and/or the long description was
changed. Depending on which description is used in
this article, there may not be any change in how the
code displays in the document: 81287, 81327, 81400,
81401, 81403, 81404, 81405, and 81407.	Revision
History
Date	Revision
History
Number	Revision History Explanation	
			HCPCS Code Group 2 and added to CPT/HCPCS Code
Group 1 in response to an inquiry; it will have no
diagnosis to procedure code restrictions at this time:
81450. This change is a clarification to ensure proper
billing. The CPT and ICD-10 codes from related LCD,
L35396-Biomarkers for Oncology, have been added in
response to CMS Change Request 10901. The coding
guidance section has been updated accordingly. There
has been no change to the LCD coverage indications as
a result of this revision.	
	04/04/2019	R21	Article revised and published on 04/04/2019 effective
for dates of service on and after 03/16/2018 to remove
CPT code 0022U from CPT/HCPCS Code Group 1 due
to implementation of NCD 90.2. Statement and link
added to ICD-10 Group 1 Paragraph stating ICD-10-
CM diagnosis codes for CPT code 0022U may be found
in NCD 90.2, Next Generation Sequencing (NGS) for
Patients with Advanced Cancer. NCD 90.2 listed as a
Related National Coverage Document.	
	01/01/2019	R20	Article revised and published on 02/14/2019 effective
for dates of service on and after 01/01/2019 to reflect
the annual CPT/HCPCS code updates. The following
CPT/HCPCS code(s) have been added to Group 1
Codes: 81233, 81236, 81237, 81305, 81320, and
81345. For the following CPT/HCPCS codes either the
short description and/or the long description was
changed. Depending on which description is used in
this article, there may not be any change in how the
code displays in the document: 81287, 81327, 81400,
81401, 81403, 81404, 81405, and 81407.	
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
	10/25/2018	R19	Article revised and published on 10/25/2018 effective
for dates of service on and after 05/18/2018 to add
billing and coding guidance for ColonSeq® and
LungSeq®.	
	10/04/2018	R18	Article revised and published on 10/04/2018 effective
for dates of service on and after 05/15/2018 to add
CPT code 0026U to CPT Group 1 Codes and billing and
coding guidance for ThyroSeq thyroid test. Effective for
dates of service on and after 05/18/2018, CPT code
0022U has been added to CPT Group 1 Codes and
billing and coding guidance for Oncomine DX has been
updated to change the CPT code from 81445 to
0022U.	
	07/26/2018	R17	Article revised and published on 07/26/2018 effective
for dates of service on and after 04/09/2018 to add
billing and coding guidance for ThyGenX and
RosettaGX Reveal Thyroid tests. Clarification added to
coding guidance for Afirma and ThyraMIR. Updated
the example for billing certain tests and corrected a
typographical error in the CPT code for Oncomine Dx.	
	03/08/2018	R16	Article revised and published on 03/08/2018 effective
for dates of service on and after 12/22/2017 to add
billing and coding guidance for Oncomine DX target
test and to add CPT code 81445 to list of CPT/HCPCS
Group 1 Codes. Link to L36715-BRCA1 and BRCA2
Genetic Testing and L35062-Biomarkers Overview
added to the Related Local Coverage Documents
section. For provider education/guidance per Annual
Review, removed Bill Types 18x and 21x as those Bill	
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
			Types are not for inpatient services claims.	
	01/01/2018	R15	Article revised and published on 01/25/2018 effective
for dates of service on and after 01/01/2018 to reflect
the annual CPT/HCPCS code updates. For the following
CPT/HCPCS codes either the short description and/or
the long description was changed: 81400, 81401,
81403, 81404, 81405, 81406. Depending on which
description is used in this article there may not be any
change in how the code displays in the document. The
following CPT/HCPCS codes have been added to CPT/
HCPCS Code Group 1: 81120, 81121, 81175, 81176,
81334, 81520. The following CPT/HCPCS code has
been deleted from CPT/HCPCS Code Group 1: 0008M.	
	11/09/2017	R14	Article revised and published on 11/09/2017 effective
for dates of service on and after 08/01/2017 to add the
following new CPT/HCPCS codes for Proprietary
Laboratory Analyses (PLA) to Group 2 CPT/HCPCS
Codes as non-covered: 0009U, 0013U, 0014U, 0016U,
and 0017U. Article revised with effective dates of
service on and after 10/02/2017 to reflect the 4Q17
CPT/HCPCS code updates. For the following CPT/
HCPCS code(s) either the short description and/or the
long description was changed: 81405 and 0002U.
Depending on which description is used in this article,
there may not be any change in how the code displays
in the document.	
	08/10/2017	R13	Article revised and published on 08/10/2017 effective
for dates of service on and after 05/01/2017 to add the
following CPT code as non-covered to Group 2 Codes:	
Revision
History
Date	Revision
History
Number	Revision History Explanation
		0005U.
06/08/2017	R12	Article revised and published on 06/08/2017 to add
coding guidance for billing multiple biomarkers
performed on one specimen.
02/01/2017	R11	Article revised and published on 05/11/2017 effective
for dates of service on and after 02/01/2017 to add the
following CPT codes as non-covered to Group 2 Codes:
0002U and 0003U.
01/01/2017	R10	Article revised and published on 01/12/2017 effective
for dates of service on and after 01/01/2017 to reflect
the annual CPT/HCPCS code updates. The following
CPT/HCPCS code 81327 has been added to group 1
CPT code group of the Article.
12/01/2016	R9	Article revised and published on 12/01/2016 effective
for dates of service on and after 12/01/2016 to add the
following CPT/HCPCS codes to Group 1: 0008M,
81219, 81262, 81316, 81437, 81438, 81525, 81540,
and 81545; and to remove the following CPT codes
from Group 2: 81445, 81455, and 81595. Article
revised and published on 12/01/2016 effective for
dates of service on and after 01/01/2017 to reflect the
annual CPT/HCPCS code updates. For the following
CPT/HCPCS code(s) either the short description and/or
the long description was changed. Depending on which
description is used in this article, there may not be any
change in how the code displays in the document:
81402 and 81407.
	Revision
History
Date	Revision
History
Number	Revision History Explanation	
	09/26/2016	R8	Article revised and published on 10/13/2016 effective
for dates of service on and after 09/26/2016 to remove
the following three requirements from OVA1 testing:
have not yet been referred to a gynecologic oncologist;
have not had cancer in the past five years; and have a
rheumatoid factor concentration <250 IU/mL.	
	03/09/2016	R7	Article revised and published on 06/09/2016 effective
for dates of service on or after 03/09/2016 to add
guidance for OVA1 testing.	
	01/01/2016	R6	Article revised and published on 02/11/2016 to add
coding guidance for ThyraMIR effective for dates of
service 12/14/2015 or after.	
	01/01/2016	R5	Article revised and published on 01/28/2016 to reflect
the annual CPT/HCPCS code updates effective for
dates of service on and after 01/01/2016. For the
following CPT/HCPCS codes, either the short
description and/or the long description was changed.
Depending on which description is used in this article,
there may not be any change in how the code displays
in the document: 81210, 81275, 81402, 81435, 81436,
81445, 81450, 81455. The following codes have been
added to CPT Group 1: 81272, 81273, 81276, 81311,
81314, 81538. The following code has been added to
CPT group 2 as NON-COVERED; 81595 please refer to
LCD L35396. CPT code 81538 has been added to #3 in
the Article Text section to replace 84999 for reporting
VeriStrat ® Assay.	
	10/01/2015	R4	Article revised and published on 10/08/2015 to reflect
that OVA1 should be reported with CPT 81503 rather	
		
Revision
History
Date	Revision
History
Number	Revision History Explanation
		than 84999 effective for dates of service on and after
10/01/2015.
10/01/2015	R3	Article revised and published on 01/23/2015 to reflect
the annual CPT/HCPCS code updates For the following
CPT/HCPCS code(s) either the short description and/or
the long description was changed. Depending on which
description is used in this article, there may not be any
change in how the code displays in the document:
81245; 81402; 81403; 81404; 81405. The following
codes have been added to CPT group 2 as NON-
COVERED; 81445, 81450 and 81455. The following
codes have been added to the article but will not have
any diagnosis to procedure code editing at this time;
81246; 81435; and 81436. CPT code 81313 has been
added to #5 in the Article Text section to replace 81479
for reporting PROGENSA® PCA3 Assay.
10/01/2015	R2	Article revised and published on 10/09/2014, effective
for dates of service 10/01/2015 to add billing and
coding information for MyPRS Genetic Expression
Profile Testing.
10/01/2015	R1	Article revised and published on 7/24/2014 to provide
billing and coding guidance regarding various Tier 1
and Tier 2 molecular pathology procedures.
Updated On	Effective Dates	Status	
